This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the fifth installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...

Researchers at the University of Tokyo have created an RNA molecule that can not just replicate, but “evolve” into a diverse range of more complex molecules. This find could plug a major gap in the ...

They say that change takes time. Well, that's not the case for RNA. The small biological molecule acts like a switchboard operator, capable of changing its shape every few milliseconds so it can ...

Cells use the genetic information contained in DNA to generate proteins, which carry out many of the processes of life. RNA is the intermediate molecule; it is transcribed from DNA, then edited, ...

Replicate Bioscience wants to replicate the success RNA technology has had in responding to the COVID-19 pandemic but with self-replicating RNAs to go after cancers and autoimmune disorders at lower ...

Zika virus hijacks a key protein implicated in brain development for its own replication. Researchers led by Associate Professor Priya Shah at the University of California, Davis (CA, USA), have ...

Replicate Bioscience emerged from stealth mode this month with an ambitious vision for how RNA treatments can combat cancer, autoimmune disease and inflammatory disorders. It’s a goal that seems more ...

Chemists at UCL and the MRC Laboratory of Molecular Biology have demonstrated how RNA (ribonucleic acid) might have replicated itself on early Earth—a key process in the origin of life. Scientists ...

Replicate Bioscience has early evidence its self-replicating RNA technology works in humans. The Apple Tree Partners biotech showed all doses of its rabies vaccine triggered protective responses, ...

Novo Nordisk is again looking for help outside its own laboratories as it works to build on the success of Ozempic and its sister medicine Wegovy. In the latest deal, Novo will provide research ...

Partnership leverages Replicate's proprietary srRNA technology to create novel, scalable therapies for obesity, type 2 diabetes and other cardiometabolic diseases Replicate will receive research ...